{"schema_version":"secwatch.filing_event.v1","accession":"0000885725-25-000024","form_type":"8-K","ticker":"BSX","cik":"0000885725","company_name":"BOSTON SCIENTIFIC CORP","filed_at":"2025-04-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.616570+00:00","generated_at":"2026-05-23T08:45:49.351128+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Boston Scientific CFO Dan Brennan to retire; Jon Monson named successor effective June 30, 2025","bullets":["Dan Brennan retires as EVP & CFO effective June 29, 2025; will remain senior advisor to October 3, 2025.","Jon Monson promoted to EVP & CFO effective June 30, 2025; previously SVP, Investor Relations and global controller.","Monson receives base salary of $700,000, bonus target of 80%, and $1.75M equity award vesting over 4 years.","Monson has been with Boston Scientific for 25+ years; played key roles in finance during pandemic and strategic investments."],"urls":{"canonical":"https://secwatch.observer/filing/0000885725-25-000024","json":"https://secwatch.observer/filing/0000885725-25-000024.json","markdown":"https://secwatch.observer/filing/0000885725-25-000024.md","text":"https://secwatch.observer/filing/0000885725-25-000024.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/885725/000088572525000024/0000885725-25-000024-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/885725/000088572525000024/bsx-20250418.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T08:45:49.351128+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"10c77468ad","claim":"Jonathan Monson was appointed as Executive Vice President and Chief Financial Officer at BOSTON SCIENTIFIC CORP.","evidence_excerpt":"Jonathan Monson, who currently serves as Senior Vice President, Investor Relations, has been promoted to Executive Vice President and Chief Financial Officer of the Company effective as of June 30, 2025","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/885725/000088572525000024/0000885725-25-000024-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"promoted"},{"label":"Role","value":"Executive Vice President and Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"ed9293db2d","claim":"Daniel J. Brennan departed as Executive Vice President and Chief Financial Officer at BOSTON SCIENTIFIC CORP.","evidence_excerpt":"On April 23, 2025, Boston Scientific Corporation (the “Company”) announced that Daniel J. Brennan has decided to retire from his role as Executive Vice President and Chief Financial Officer of the Company effective as of June 29, 2025","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/885725/000088572525000024/0000885725-25-000024-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retire"},{"label":"Role","value":"Executive Vice President and Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}